SCHEMBL21775685

SCHEMBL21775685

CSc1c(C)nc2cc(-c3ccc(Cl)cc3Cl)nn2c1N1CCCC(C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HSD17B10 Q99714 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NOTUM Q6P988 2/20 0.42
DPP4 P27487 5/20 0.42
DPP8 Q6V1X1 3/20 0.42
DPP9 Q86TI2 2/20 0.42
ENPP2 Q13822 1/20 0.41
LMNA P02545 2/20 0.40
USP2 O75604 1/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21774117 0.92 KDM4E (0.44) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21774100 0.92 KDM4E (0.45) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775583 0.91 KDM4E (0.56) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21774123 0.91 KDM4E (0.56) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775635 0.89 IDH2 (0.41) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775878 0.88 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775789 0.87 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775677 0.84 KDM4E (0.46) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775791 0.84 KDM4E (0.44) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL21775695 0.84 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 KDM4E 2972/4885ALDH1A1 585/4885HPGD 1684/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 KDM4E 2972/4885ALDH1A1 585/4885HPGD 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.